Regulatory Affairs and the Jurisdiction Map What Governs a Trial, Country by Country
What regulatory affairs owns and how it is done across borders: the global GCP baseline and what it does not settle, reading a jurisdiction from its primary sources, the European coordinated procedure, the United States framework, national instruments from Japan to Nigeria, submission sequencing and import, safety reporting obligations, inspections, and building a jurisdiction map you can defend. Grounded in 45 jurisdictions verified against named primary instruments.
30 lessons, about 159 minutes. Free, in your language.
What Regulatory Affairs Owns
The Global GCP Baseline
Reading a Jurisdiction
The European Union under CTR 536/2014
The United States under 21 CFR
Jurisdictions with Their Own Instruments
Submissions and the Critical Path
Safety Reporting Obligations
Inspections and Regulatory Correspondence
Building and Defending a Global Position
Free courses What Regulatory Affairs Actually Owns Competent Authority, Ethics Committee, and Who Decides What The Regulatory Dossier and What It Must Prove ICH E6(R3) as the Common Floor Members, Observers, and Jurisdictions That Are Neither Where National Law Overrides the Baseline Finding the National Instrument, Not the Summary The Authority, Its Maturity, and What Benchmarking Says When What You Found Is Not What Is in Force One Application, One Decision, Many Member States CTIS, the Reporting Member State, and the Single Portal Timelines, Clock Stops, and What Silence Means The IND and the Thirty Day Clock Form FDA 1572 and What Signing It Commits Review Board Oversight and the Consent Rules The Long-Standing National Frameworks Large Markets with Distinct National Rules Africa and Latin America: Named Instruments, Real Requirements Sequencing a Multi-Country Submission Import Licenses, Customs, and What Is Not in the Dossier Substantial Modifications Across Jurisdictions SUSARs: Who Must Be Told, Inside What Clock Annual Safety Reporting and the Development Safety Update Report Urgent Safety Measures and Stopping a Trial Who Inspects, on What Authority, and What They May Demand Answering a Regulatory Question Without Creating a New Obligation Findings That Cross Borders The Jurisdiction Map as an Operational Artifact Provisional, Verified, and How Not to Over-Claim Keeping a Regulatory Position Current All clinical research training